SEI INVESTMENTS CO

Position in ANIP — Ani Pharmaceuticals Inc

CIK 350894 OAKS, PA

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,572,535

-$823,682 QoQ

Shares Held

43,157

-24.5% QoQ

Ownership

0.188%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#83

of 305 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. ANIP ranks #17 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	5,284,773	$130,058,261
2	VTRS	Viatris Inc	3,165,469	$50,267,647
3	TEVA	Teva Pharmaceutical Industries Ltd	1,105,005	$37,437,568
4	NBIX	Neurocrine Biosciences Inc	185,545	$31,271,754
5	ZTS	Zoetis Inc.	237,394	$17,059,132
6	KNSA	Kiniksa Pharmaceuticals International, plc	188,565	$12,058,731
7	AMRX	Amneal Pharmaceuticals, Inc.	690,897	$11,959,425
8	LNTH	Lantheus Holdings, Inc.	98,305	$10,905,956

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,572,535	43,157	-24.5%	Shares	Defined	2026-08-14
2026-03-31	$4,396,217	57,168	+36.8%	Shares	Defined	2026-05-13
2025-12-31	$3,299,770	41,801	+78.5%	Shares	Defined	2026-02-13
2025-09-30	$2,145,179	23,419	+170.2%	Shares	Defined	2025-11-13
2025-06-30	$565,456	8,666	-13.7%	Shares	Sole	2025-08-14
2025-03-31	$672,244	10,041	-55.9%	Shares	Sole	2025-05-14
2024-12-31	$1,258,945	22,774	+13.7%	Shares	Sole	2025-02-11
2024-09-30	$1,194,512	20,022	+38.3%	Shares	Sole	2024-11-12
2024-06-30	$921,640	14,473	+27.8%	Shares	Sole	2024-08-13
2024-03-31	$782,620	11,321	+16.4%	Shares	Sole	2024-05-07
2023-12-31	$536,346	9,727	-22.6%	Shares	Sole	2024-02-14
2023-06-30	$676,535	12,568	-21.2%	Shares	Sole	2023-08-11
2023-03-31	$633,812	15,957	+34.6%	Shares	Sole	2023-05-12
2022-12-31	$477,047	11,858	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.